Industry Perspectives

Plasmidsaurus expands RNA-seq capabilities with Cologne hub and Genovis partnership

The new Cologne hub and partnership with Genovis provide faster, localized RNA-seq and ambient RNA shipping for European researchers.
Brought to you byPlasmidsaurus
| 2 min read
RNA strand

istock.com/Artur Plawgo

Register for free to listen to this article
Listen with Speechify
0:00
2:00

COLOGNE, GERMANY & SAN FRANCISCO, CA - Plasmidsaurus, the leading Sequencing as a Service company, has announced two transformative evolutions of its RNA-Seq ecosystem: the launch of a high-capacity RNA sequencing hub in Cologne, Germany, and a global partnership with Genovis to release SEQguard Dino Preserve, an RNA preservation solution that enables ambient shipping of purified RNA samples for sequencing.

The Plasmidsaurus mission is to accelerate science with the best sequencing. With these updates, they are continuing to dismantle the barriers in transcriptomics to bring affordable, accessible sequencing to their community of innovators worldwide. While these milestones represent independent achievements, they converge on a single goal: a modernized, "frictionless" workflow that ensures science gets the best sequencing it deserves.

Expanding the European Footprint: From the UK to Cologne

The addition of RNA-seq services into the Plasmidsaurus Cologne facility marks a significant advancement of the Plasmidsaurus European infrastructure. Building on the success of the company's established presence in the United Kingdom, this new capability brings lightning-fast RNA-Seq directly into the heart of the European Union.

This expansion is about more than just proximity; it is a commitment to a sustainable, localized service model that delivers fast, reliable answers to the questions driving research. By processing RNA samples directly within the EU, Plasmidsaurus drastically reduces transit distances and cuts carbon emissions, allowing researchers to bypass the logistical hurdles of international borders. Now, European RNA researchers can utilize the ever-expanding network of Plasmidsaurus dropboxes and an optimized regional pipeline to provide a 3-day turnaround time, moving from sample to insight faster than ever.

The Shipping Revolution: Breaking the Ice with Genovis

In a separate milestone, Plasmidsaurus announced the launch of SEQguard Dino Preserve, an RNA preservation solution developed through a strategic partnership with Genovis AB. SEQguard Dino Preserve has been tested and optimized for seamless integration into Plasmidsaurus RNA-Seq workflows, enabling researchers to ship purified RNA samples at ambient temperatures without compromising the high sequencing quality they have come to expect from Plasmidsaurus.

For decades, high costs, bulky packaging, and environmental impact of dry ice shipments required to safely ship precious purified RNA-seq samples, have been a mandatory burden for researchers. SEQguard Dino Preserve eliminates this requirement entirely in a single, simple step. The solution remains active across a wide temperature range and tolerates freeze-thaw cycles, enabling reliable ambient shipping year-round, and ensuring stability from the bench to the Plasmidsaurus dropbox without the hassle of dry ice.

SEQguard Dino Preserve key specifications:

  • Synthetic: Reduces batch variability and eliminates cell-based contaminants.
  • Thermostable Protection: Reliable RNA integrity despite ambient temperature swings.
  • Sustainability: Energy-efficient synthesis and storage, with ambient shipping and room temperature stability, which mean no dry ice shipments.
  • Efficiency: One 150 μl vial stabilizes 24 purified RNA samples.
  • Storage: Shipped and stored at room temperature (15–30°C).

Accelerating Discovery

“By partnering with Genovis to bring SEQguard Dino Preserve into the Plasmidsaurus ecosystem, we’re making high-quality RNA-seq as simple and reliable as dropping off a tube at a local dropbox. Together, we eliminate the logistical headache so customers can focus on their science, not shipping, unlocking unprecedented simplicity for ultrafast, high-quality gene expression data,” said Mark Budde, CEO and co-founder of Plasmidsaurus.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Scientists in a laboratory conducting pharmaceutical research using laboratory equipment and analytical instruments.
Explore a strategic guide to IND-enabling nonclinical development for small molecules and biologics.
Digital illustration of a human brain composed of glowing neural connections, surrounded by colorful, blurred lights against a dark blue background.
Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across brain organoid networks.
3D illustration of a Y-shaped antibody with pink and blue molecular structures against a blurred pink and purple background.
Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into binding behavior and antibody function.